<p>Animals were injected intravenously (in tail vein) with anti-PECAM/SOD (25 µg/mouse), PAPA NONOate (prepared immediately before use, 0.1 mM final concentration, based on blood volume of 7.5% of body weight) or their combination. LPS (200 µg/kg) was injected same way in 30 min. Lung tissue and plasma were harvested in 5 h. Lung VCAM level was assayed by Western blotting: (A), representative image; (B), Western blotting analysis. Plasma TNF and MIP-2 concentrations were measured by corresponding ELISA (C and D, respectively). Means ± SEM are shown; n≥3, * p≤0.05 vs. LPS-treated group; # p≤0.05 vs. LPS+NO group.</p
<p>(A) WT mice were intravenously treated with LPS (10 µg per mouse) or LPS-liposomes (10 µg per mou...
<p>Mice were treated with PBS or LPS once a day intranasally for four days. On day 5, whole lungs fr...
<p>WT mice in Con, LPS or LPS+TI group were injected with saline, LPS, or LPS plus TI as described a...
<p>Lung slices from naïve mice were cultured in the absence or presence of LPS (10 μg/ml) for 2, 18 ...
<p>(A) 1400W (10 mg/kg body weight) was used to treat mice at 1 h prior to LPS (10 mg/kg body weight...
<p>(A–B). Western blotting analysis of IκBα phosphorylation. HUVEC were treated with SNAP (0.2 mM), ...
<p>(A) The bioavailability property of SR12460, SR12343, SR12454, and SR11481. Concentrations of NBD...
<p>BM and SCM were activated with LPS to measure the difference in their pro-inflammatory molecules ...
<p>Peritoneal Macrophages from WT and <i>Txnip<sup>−/−</sup></i> mice on the C57BL/6 background were...
<p>Mice were administered LPS (2 mg/kg, s.c.), CORT (20 mg/kg) or CORT (20 mg/kg) 30 minutes prior t...
<p>A and B, TNF-α release in BAL fluid obtained from WT (n = 4–5) and β-arrestin 2<sup>−/−</sup> mic...
<p>Female WT (C57BL6) and VIP KO mice were injected i.p. with LPS (40 mg/Kg). A, Kaplan Meier curve ...
<p><b>(A)</b> C57BL/6 mice (n = 8) either untreated or treated with antibiotic formula (Ab) were giv...
<p>(A) Statistical data showing that pretreatment with PES (1 and 5 mg/kg, 1 h) reduced serum nitrit...
<p>We treated <i>Spred-2<sup>−/−</sup></i> mice intranasally with 20 µL of 5 mM U0126 (n = 6) or DMS...
<p>(A) WT mice were intravenously treated with LPS (10 µg per mouse) or LPS-liposomes (10 µg per mou...
<p>Mice were treated with PBS or LPS once a day intranasally for four days. On day 5, whole lungs fr...
<p>WT mice in Con, LPS or LPS+TI group were injected with saline, LPS, or LPS plus TI as described a...
<p>Lung slices from naïve mice were cultured in the absence or presence of LPS (10 μg/ml) for 2, 18 ...
<p>(A) 1400W (10 mg/kg body weight) was used to treat mice at 1 h prior to LPS (10 mg/kg body weight...
<p>(A–B). Western blotting analysis of IκBα phosphorylation. HUVEC were treated with SNAP (0.2 mM), ...
<p>(A) The bioavailability property of SR12460, SR12343, SR12454, and SR11481. Concentrations of NBD...
<p>BM and SCM were activated with LPS to measure the difference in their pro-inflammatory molecules ...
<p>Peritoneal Macrophages from WT and <i>Txnip<sup>−/−</sup></i> mice on the C57BL/6 background were...
<p>Mice were administered LPS (2 mg/kg, s.c.), CORT (20 mg/kg) or CORT (20 mg/kg) 30 minutes prior t...
<p>A and B, TNF-α release in BAL fluid obtained from WT (n = 4–5) and β-arrestin 2<sup>−/−</sup> mic...
<p>Female WT (C57BL6) and VIP KO mice were injected i.p. with LPS (40 mg/Kg). A, Kaplan Meier curve ...
<p><b>(A)</b> C57BL/6 mice (n = 8) either untreated or treated with antibiotic formula (Ab) were giv...
<p>(A) Statistical data showing that pretreatment with PES (1 and 5 mg/kg, 1 h) reduced serum nitrit...
<p>We treated <i>Spred-2<sup>−/−</sup></i> mice intranasally with 20 µL of 5 mM U0126 (n = 6) or DMS...
<p>(A) WT mice were intravenously treated with LPS (10 µg per mouse) or LPS-liposomes (10 µg per mou...
<p>Mice were treated with PBS or LPS once a day intranasally for four days. On day 5, whole lungs fr...
<p>WT mice in Con, LPS or LPS+TI group were injected with saline, LPS, or LPS plus TI as described a...